Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2870 Carcinoma, Non-Small-Cell Lung 2420 Breast Neoplasms 2065 Colorectal Neoplasms 1239 Neoplasm Metastasis 1223 Prostatic Neoplasms 1076 Melanoma 972 Multiple Myeloma 960 Ovarian Neoplasms 899 Recurrence 849 Leukemia, Myeloid, Acute 807 Lung Neoplasms 756 Pancreatic Neoplasms 750 Lymphoma, Non-Hodgkin 726 Lymphoma 660 Stomach Neoplasms 622 Carcinoma, Hepatocellular 564 Carcinoma, Renal Cell 544 Squamous Cell Carcinoma of Head and Neck 525 Leukemia, Lymphocytic, Chronic, B-Cell 493 Lymphoma, Follicular 468 Head and Neck Neoplasms 449 Glioblastoma 435 Advanced Solid Tumors 430 Small Cell Lung Carcinoma 408 Triple Negative Breast Neoplasms 407 Lymphoma, Large B-Cell, Diffuse 398 Leukemia 394 Uterine Cervical Neoplasms 367 Advanced Solid Tumor 349

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Pre-menopausal Breast Cancer × Clear all

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡